Weighted Average Number of Shares Outstanding, Diluted of Lunai Bioworks Inc. from 31 Mar 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Lunai Bioworks Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2014 to 31 Dec 2025.
  • Lunai Bioworks Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 23,482,714, a 45% increase year-over-year.
  • Lunai Bioworks Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 165,061,967, a 69% increase from 2024.
  • Lunai Bioworks Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 97,511,557, a 73% increase from 2023.
  • Lunai Bioworks Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 56,265,362, a 7.1% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Lunai Bioworks Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 23,482,714 +7,300,193 +45% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q2
Q3 2025 22,520,245 +6,520,908 +41% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 165,061,967 +67,550,410 +69% 01 Apr 2025 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 163,930,470 +54,680,833 +50% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 16,182,521 -49,669,976 -75% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q2
Q3 2024 15,999,337 -48,481,416 -75% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q1
Q2 2024 97,511,557 +41,246,195 +73% 01 Apr 2024 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q1 2024 109,249,637 +53,275,032 +95% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q3
Q4 2023 65,852,497 +10,343,258 +19% 01 Oct 2023 31 Dec 2023 10-Q 19 Feb 2025 2025 Q2
Q3 2023 64,480,753 +9,381,280 +17% 01 Jul 2023 30 Sep 2023 10-Q/A 19 Feb 2025 2025 Q1
Q2 2023 56,265,362 01 Apr 2023 30 Jun 2023 10-K/A 19 Feb 2025 2024 FY
Q1 2023 55,974,605 01 Jan 2023 31 Mar 2023 10-Q/A 19 Feb 2025 2024 Q3
Q4 2022 55,509,239 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 55,099,473 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q1 2015 9,533,290 +2,653,012 +39% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q1 2014 6,880,278 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015 2015 Q1

Lunai Bioworks Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 165,061,967 +67,550,410 +69% 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
2024 97,511,557 +41,246,195 +73% 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025 2025 FY
2023 56,265,362 +3,737,338 +7.1% 01 Jul 2022 30 Jun 2023 10-K/A 19 Feb 2025 2024 FY
2022 52,528,024 01 Jul 2021 30 Jun 2022 10-K 02 Oct 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.